PeptMentor
CalculatorsHow we source
PeptMentor
PeptMentor
Peptides
Eloralintide
Retatrutide
GHK-Cu
Pinealon
KPV
KLOW
All peptides
Compared
Eloralintide vs cagrilintide
Eloralintide vs retatrutide
Retatrutide vs tirzepatide
Guides and tools
Bac water for peptides
How to reconstitute peptides
Peptide reconstitution calculator
All guides
About
How we source
About
Editorial policy
Open the peptide calculator
PeptMentor

Plain answers about peptides and GLP-1 medicines. Every figure links to its source and says what kind of study it came from.

No dose advice. No sponsors, sellers or affiliate codes.

Peptides

  • Eloralintide
  • GHK-Cu
  • KLOW
  • KPV
  • Pinealon
  • Retatrutide
  • All peptides

Compare

  • Eloralintide vs cagrilintide
  • Eloralintide vs retatrutide
  • Retatrutide vs tirzepatide

Guides and tools

  • Peptide reconstitution calculator
  • Bac water for peptides
  • How to reconstitute peptides
  • All guides

About us

  • About
  • How we check facts
  • Editorial policy
  • Sources
  • Contact
© 2026 PeptMentor LLC. For information only, not medical advice. In an emergency call 911.
Medical disclaimerTermsPrivacyConsumer health data
  1. /Home
  2. /Peptides
  3. /GHK-Cu

Copper peptide · skin and hair · small studies

GHK-Cu: evidence for skin and hair

A copper peptide found in skin creams and serums, and also sold online in vials. Small skin studies give mixed results, and nobody has tested shots in people. Whether you are curious, starting, or already using it, here is what helps.

A woman applying moisturiser to her cheek in a bright bathroom
StatusNot an approved drug
How sure is science?Small studies in people
Best human resultMore brow hairs, 18 people, 12 weeks
Injection studies in peopleNone

Status as of November 17, 2026. For information only, not medical advice: read the medical disclaimer.

Where are you with GHK-Cu?

Before you decide

Good place to start. Here is what we would want to know before deciding, in plain words.

It is not an approved drug

FDA has never approved GHK-Cu, so there is no label to follow. Creams and other non-injected forms are on an FDA list pharmacies can work from for now. The injected form is on no list, and FDA plans to review it by the end of February 2027.

Status timeline →

What skin studies found

Every human study put it on the skin, and they were small. In the best hair result, 18 people had more eyebrow hairs on the treated side after 12 weeks. Two other trials found no benefit you could measure.

Small human studyEvery human study →

Shots are a different question

Cream results say nothing about injections. No study has tested GHK-Cu shots in people, so no one knows a safe amount. FDA says injected GHK-Cu may set off an immune reaction.

What the evidence says →

For hair, there is an approved option

Minoxidil is an FDA-approved hair regrowth drug. No trial has compared GHK-Cu with it.

GHK-Cu vs minoxidil →

Take these questions to your doctor or dermatologist

  • Is there an approved treatment for my skin or hair problem, such as minoxidil for hair loss?
  • What change could I expect from a copper peptide, and by when?
  • Is it safe with the other skin products and medicines I use?
  • Someone offered me GHK-Cu shots. What is the evidence, and where does the product come from?
  • What would a reaction look like, and what should I do if I have one?

Coming Pick your questions and print them as one page.

Your first weeks

Using it on your skin is the better-studied route. Injecting it has no human studies at all. Here is what helps with each.

Using a skin product: set a baseline

The trials judged results after 12 weeks, so early weeks rarely tell you much.

  • Before you start, take photos of the area in the same light, spot and angle.
  • Write down the product name, its strength and how often you use it.
  • Pick fixed check days, such as once every 4 weeks.
How to track it →

Study strengths are not advice

The trials used their own products, such as a 2% serum or a 0.4% cream. Those are study details, not a guide for you.

What the studies used →

Injecting it: no studied dose exists

No human study has tested any injected amount. Daily amounts and cycles you see online have no study behind them. If you go ahead anyway, tell your doctor first.

Why there is no dose →

Mixing a vial? Do the maths first

The calculator turns the numbers on your label into concentration and syringe units. It never suggests an amount. For clean mixing steps, see how to reconstitute peptides.

Open the calculator →

Living with it

You’re using it. Here’s how to tell if it’s working and what to watch for, on the skin or by injection.

On your skin: is it working?

  • Take the same photos on your check days.
  • Compare photos side by side, not from memory.
  • Note any redness, itching or rash, with the date.
The full checklist →

On your skin: what safety data show

In the eyebrow trial, none of 18 people had a serious side effect or an allergic reaction. That group is too small to rule out rare reactions.

Small human studySide effects →

By injection: what is unknown

There are no human safety data for shots. Nobody has studied injection-site reactions, copper build-up or long-term use. FDA has logged 3 recalls of GHK-Cu for injection, for sterility or process problems.

Source: openFDA recall records[1]

Got vials online? Lower the risk.

No judgement. We won’t tell you where to buy or how much to take, but these steps lower the risk whatever you use:

  • A label saying “research use only” or “not for human consumption” means it was not made or checked for people.
  • Injecting GHK-Cu has not been tested in people. FDA has recalled injectable GHK-Cu over sterility, so clean technique matters: see how to reconstitute peptides.
  • Tell your doctor what you are taking, even if it feels awkward. It changes what they watch for.
  • Learn the warning signs in “When to get help” before you need them.
  • Report a bad reaction to the FDA’s MedWatch[2]. It helps everyone.
Source: FDA MedWatch[2]

When to get help

GHK-Cu has no drug label, so there is no official list of warning signs for it. These general signs come from MedlinePlus and apply to any product.

Emergency: call 911 (or your local emergency number). Possible overdose or wrong amount: Poison Help, 1-800-222-1222, free and open 24 hours. Report a bad reaction to the FDA through MedWatch.

Get emergency help now if you have

These can be signs of a severe allergic reaction (anaphylaxis). Call 911 or your local emergency number.

  • Swelling of your face, eyes or tongue, or trouble breathing or swallowing.
  • Wheezing, chest tightness, dizziness or fainting, especially soon after using a product.
Source: MedlinePlus: Anaphylaxis[3]

Call your doctor if a skin product

Stop using the product and wash the area with plenty of water.

  • Causes a severe skin reaction.
  • Does not get better after treatment.
  • Leads to signs of infection: tenderness, redness, warmth or fever.
Source: MedlinePlus: Contact dermatitis[4]

If you injected it and feel unwell

There are no human data on what to expect from shots, so do not wait it out. Talk to a doctor or pharmacist, and tell them it was GHK-Cu.

What is known →

The science, if you want it

Every number below says what kind of study it came from. Bracketed numbers point to the sources listed at the end.

Small human studies (topical only)No injection studiesNot FDA approved
CellAnimalSmall humanHuman randomised trialApproved

Best evidence: small human

Facts checked 2026-11-17 · by PeptMentor Team · How we source

On this page
At a glanceWhat the trials saw, week by weekLiving with it day to daySide effects: what's known and when to get helpIs it working? How to track itYour appointment checklist (dermatologist or prescriber)What is GHK-Cu?What has been studied in peopleSkin and hair: what the trials foundGHK-Cu injection: what the evidence saysGHK-Cu doses studiedGHK-Cu vial calculatorSide effects reportedIs GHK-Cu FDA approved? Status timelineGHK-Cu compared with minoxidil and other optionsGHK-Cu: questions people askSources

At a glance

Key takeaways
  • GHK-Cu is a copper peptide used in skin care. It is not an approved drug.
  • Every human study put it on the skin. The studies were small, and two found no benefit.Small human studyReview[5]
  • The best hair result is one trial of 18 people's eyebrows over 12 weeks.Small human studyBo 2026[6]
  • No study has tested GHK-Cu shots in people. FDA has logged 3 recalls of GHK-Cu for injection.RegulatoropenFDA recall records[1]
  • If you use a cream or serum, judge it with photos taken the same way on a fixed schedule.
I'm…New to copper peptidesAlready using a serumThinking about injectionsWorried about a side effectSeeing a dermatologist

What the trials saw, week by week

Two 12-week trials of GHK-Cu on the skin
  1. Day 1Bo 2026
    Twice a day, one brow each

    In the eyebrow trial, each person put a 2% GHK-Cu serum on one brow. The other brow got a dummy serum. Nobody knew which was which.

    Small human studyBo 2026[6]
  2. Weeks 1 to 12Bo 2026
    No checks in between were reported

    Both trials, the eyebrow trial and a 2006 laser trial[7], kept going for 12 weeks. The reports give results at the end only. So there is no data on when a change might start.

    Small human studyBo 2026[6]
  3. Week 12: browsBo 2026
    More hairs on the treated side

    The hair count went up on the GHK-Cu side and not on the dummy side. The paper does not say by how much. Nobody had a serious side effect or an allergic reaction.

    Small human studyBo 2026[6]
  4. Week 12: skinMiller 2006, PMID 16847171
    No change you could measure

    After laser skin treatment, skin care with GHK-Cu did not reduce redness or wrinkles on objective tests. People did rate their own skin as better.

    Human randomised trialMiller 2006[7]

Averages from trials, not a forecast for you. Sources: Bo 2026[6], 18 adults, 2% serum on one eyebrow and a dummy serum on the other; Miller 2006[7], 13 people after laser skin treatment. Small cosmetic reports from 1998 to 2002 are left out because they were never published as full papers.

Living with it day to day

There is no label to follow. GHK-Cu has never been approved as a drug, so no FDA label tells you how to use or store it. The trials used their own products, such as a 2% serum twice a day[6] or a 0.4% cream[8]. Those are study details, not advice.

What it can and can't do for skin. One wound trial run by the product's sponsor found faster healing[9]. A second wound trial found no benefit[8]. The laser trial found no change on objective tests[7]. A 2025 review adds that GHK-Cu gets through skin poorly[10].

What it can and can't do for hair. The only direct evidence is the 18-person eyebrow trial[6]. No trial has tested GHK-Cu alone on scalp hair loss. No trial has compared it with minoxidil, an approved hair-loss treatment.

Why injection is a different question. Results from creams say nothing about shots. No study has tested injected GHK-Cu in people[11]. FDA says injected GHK-Cu may set off an immune reaction, meaning your body's defences react to it[12]. FDA has also logged 3 recalls of GHK-Cu for injection, for sterility or process problems[1].

Side effects: what's known and when to get help

On the skin. In the eyebrow trial, none of the 18 people had a serious side effect or an allergic reaction[6]. That is a small group, so a rare reaction would not show up.

As a shot. There are no human safety data at all. FDA's concern is a possible immune reaction to clumped peptide and impurities[12].

GHK-Cu has no drug label, and we found no official guidance on what to watch for with it, so we do not make up a GHK-Cu-specific list. The general allergy and skin-reaction signs in “Something feels off” at the top of this page come from MedlinePlus and apply to any product. If a product bothers your skin or you feel unwell, talk to a doctor or pharmacist.

Is it working? How to track it

A simple way to judge a cream or serum
  • Before you start, take photos of the area. Use the same light, spot and angle.
  • Pick fixed check days, such as once every 4 weeks. Take the same photos each time.
  • For brows or hair, photograph the same small patch each time.
  • Write down the product name, its strength and how often you use it.
  • Note any redness, itching or rash, with the date.
  • Compare photos side by side, not from memory.

This is a way to keep notes, not a medical test. The trials judged results after 12 weeks[6][7].

Your appointment checklist (dermatologist or prescriber)

Bring these to your appointment
  • Is there an approved treatment for my skin or hair problem, such as minoxidil for hair loss?
  • What change could I expect from a copper peptide, and by when?
  • Is it safe with the other skin products and medicines I use?
  • How should I check if it is working, and when should I stop?
  • Someone offered me GHK-Cu shots. What is the evidence, and where does the product come from?
  • What would a reaction look like, and what should I do if I have one?

Any dose question belongs here. For shots, no dose has been studied, so there is no trial figure to point to.

What is GHK-Cu?

What it is, where it comes from, and its chemistry.

GHK-Cu is also written GHK Cu, GHKCu or GHK.

GHK-Cu in short

What it is: the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine[13]. Status: not FDA approved. Topical: 503A category 1, non-injectable routes only, since May 2026. Injectable: on no 503A list; an FDA advisory committee review is planned before the end of February 2027[14]. Evidence: small human studies, topical only; no human data for injection.

0

Published human studies of injected GHK-Cu[11]

Animal
2 of 20

Studies in a 2026 systematic review that were human RCTs[5]

Human randomised trial
3

FDA Class II recalls of injectable GHK-Cu, 2020 to 2026[1]

Regulator
Feb 2027

Deadline FDA set for advisory committee review of the injectable form[14]

Regulator
Best evidence so far
CellAnimalSmall humanHuman randomised trialApproved

Best evidence: small human

Topical GHK-Cu reaches small human studies. Injected GHK-Cu has no human study at all; its evidence stops at animal and cell work.

What GHK stands for. G, H and K are the one-letter codes for glycine, histidine and lysine. GHK binds copper tightly, and the copper complex is what "GHK-Cu" and "copper peptide" refer to[13]. The spellings ghkcu, ghku and ghk cu all mean the same compound.

Where it comes from. GHK was first described in 1973 as a factor in human serum that kept liver cells alive in culture (cell study)[15]. A review by its discoverer puts plasma levels at about 200 ng/mL at age 20 and about 80 ng/mL at age 60[16]; we could not trace the original measurement, so treat that figure as a review claim. A separate study measured 70.27 ng/mL in 9 people with COPD and 133.0 ng/mL in 11 healthy controls[17].

Chemistry and half-life. GHK-Cu is highly water-soluble and breaks down under basic and oxidative conditions (lab study)[18]. No human pharmacokinetic study exists, so its half-life in people is unknown. A 2026 review expects a short half-life because peptidases cut small peptides quickly, but gives no measured value[19]. Half-life figures quoted online have no source.

What has been studied in people

Every human study, including the two that found no benefit.

A 2026 systematic review of GHK-Cu as a stand-alone aesthetic treatment found 20 eligible studies: 18 preclinical and 2 randomised controlled trials[5]. Every human study we found used GHK-Cu on the skin. The table lists them all, including the ones that found nothing.

StudyDesign and sizeWhat was appliedResultStudy type
Mulder 1994[9], diabetic foot ulcersRandomised, evaluator-blinded, vehicle-controlled; n not in abstract; sponsor ran the trialGHK-Cu gel daily vs vehicle vs standard care; strength not in abstractPlantar ulcers: median closure 98.5% vs 60.8% with vehicle; infection 7% vs 34%Human RCT
Bishop 1992[8], venous leg ulcersRandomised, evaluator-blinded; 86 evaluable0.4% copper peptide cream vs silver sulfadiazine 1% vs inert creamNegative: the copper cream did no better than the inert creamHuman RCT
Miller 2006[7], after CO2 laser resurfacingRandomised, blinded evaluators; 13 completedSkin care with vs without GHK-Cu, 12 weeksNegative on objective measures (redness, wrinkles); patients rated skin quality betterSmall human RCT
Bo 2026[6], sparse eyebrowsRandomised, double-blind, one brow each; 18 adults2% GHK-Cu serum twice daily vs placebo serum, 12 weeksHair count rose on the GHK-Cu side only; no effect sizes givenSmall human RCT (journal not indexed in PubMed)

Human studies of topical GHK-Cu. Where a figure is missing, the abstract does not give it and we have not read the full text.

Studies often cited for GHK-Cu that cannot isolate it. A 45-man hair trial used GHK combined with 5-aminolevulinic acid, with no copper stated[20]. Two large scalp-injection reports used mixes of 6 to 14 ingredients that included copper tripeptide[21][22]. Two open-label studies by manufacturer-employed authors tested multi-ingredient products[23][24]. None of these tells you what GHK-Cu alone does. Several cosmetic reports from 1998 to 2002 are quoted in reviews but were never published as full papers we could check, so we leave them out.

Mechanism: lab and animal only. These findings explain why GHK-Cu is studied. They do not show an effect in people.

FindingModelSourceStudy type
More collagen made by fibroblastsCell culture[25]Cell
Faster fibroblast growth; more bFGF and VEGF at 1 nMHuman fibroblasts in culture[26]Cell
Changes the activity of "at least 4,000 human genes"Gene-expression data from cell lines, reported in a review[16]Cell
Activates SIRT1; less smoke-induced muscle lossMice, 0.2 and 2 mg/kg[17]Animal
Less airway remodellingAsthmatic mice[27]Animal

Skin and hair: what the trials found

Wound, skin and hair trials, study by study.

Skin and wound healing. The two wound trials split: one positive diabetic-ulcer trial run by the product's sponsor[9] and one negative venous-ulcer trial[8]. The small post-laser trial found no difference on objective measures[7]. A 2025 review notes that clinical studies of topical GHK-Cu are surprisingly scarce and that the peptide passes through skin poorly[10]. A phase 2 trial of a 0.1% GHK-Cu gel on skin wounds is recruiting 60 people, with primary completion expected 2027-02-14[28].

Hair. The only direct human evidence is the 18-person eyebrow trial of a 2% serum[6]. The 45-man scalp trial used GHK without stated copper, combined with another active ingredient[20]. A study often cited for hair follicle growth used AHK-Cu, a different copper peptide, on follicles in a dish[29]. No trial has measured how long GHK-Cu takes to show results on hair.

GHK-Cu injection: what the evidence says

No human studies, FDA’s concern and three recalls.

No human study of injected GHK-Cu has been published, and none is registered on ClinicalTrials.gov (searched 2026-11-17). A 2026 orthopaedic review states that no clinical data support its use for musculoskeletal conditions[11]. FDA's safety page says injected GHK-Cu may trigger immune reactions because the peptide can clump and carry impurities, and that human data are limited[12].

FeatureTopical GHK-CuInjected GHK-Cu
Human trialsSmall; mixed results[5]None[11]
FDA 503A statusCategory 1 since 2026-05-14[14]On no list; advisory review due by Feb 2027[14]
Registered trials[28], recruitingNone found
FDA safety concernNone stated for topical usePossible immunogenicity[12]
FDA recallsNone found3 Class II recalls[1]
Recall dateProductReasonFDA recall number
2020-11-30GHK-Cu 10 mg/mL, 5 mL vialLack of sterility assuranceD-0141-2021[1]
2025-07-30GHK-Cu for injection, all strengthsLack of sterility assuranceD-0051-2026[1]
2026-10-19GHK-Cu 10 mg/mL, 3 mL multi-dose vialLack of processing controlsD-0129-2027[1]

These are product-quality events. They tell you about manufacturing, not about how often people react to the drug.

We found no human data on nasal or oral GHK-Cu either.

GHK-Cu doses studied

Strengths used in skin trials; no injection dose exists.
No injection dose has been studied
No human study has tested injected GHK-Cu, so there is no studied injection dose, per day or per week (ClinicalTrials.gov search 2026-11-17)[11][5][19].

Topical strengths used in human studies. These are the products the trials applied to skin. They are not a guide for anyone.

StudyUseStrengthHow oftenHow longStudy type
Bo 2026[6]Eyebrows2% serumTwice daily12 weeksSmall human RCT
Bishop 1992[8]Venous leg ulcers0.4% creamNot in abstractNot in abstractHuman RCT
Mulder 1994[9]Diabetic foot ulcersMetered-dose gel; strength not in abstractDailyNot in abstractHuman RCT
Miller 2006[7]After laser resurfacingNot in abstractNot in abstract12 weeksSmall human RCT
[28] (ongoing)Skin wounds0.1% gel, about 0.5 gOnce daily14 daysTrial registry

Animal and cell amounts, not converted. Lab amounts do not translate into human doses, and we do not convert them.

ModelAmount as publishedSourceStudy type
Mice (smoke-induced muscle loss)0.2 and 2 mg/kg[17]Animal
Human fibroblasts in culture1 nM[26]Cell
Hair follicles in a dish (AHK-Cu, a different peptide)10⁻¹² to 10⁻⁹ M[29]Cell

Figures that circulate online without a source. Daily milligram amounts, on/off schedules and multi-week cycles for injected GHK-Cu appear on many sites. We searched for the studies behind them and found none. Questions such as "how much GHK-Cu per day" or "how much in my 50s" have the same answer: no study has tested any injected amount.

GHK-Cu vial calculator

No injection dose has been studied
This tool does arithmetic only. It turns the numbers on your own label into concentration and syringe units. It does not suggest an amount.

Before you use the calculator

  • It does arithmetic on the numbers you type from your own label. It does not suggest an amount or say whether anything is safe for you.
  • It is not medical advice. Check every result with your pharmacist or prescriber before you use it.
  • Its units are for U-100 insulin syringes only (the box or barrel says U-100).
  • In an emergency call 911. For a possible overdose call Poison Help at 1-800-222-1222.

Your answer is saved only in this browser so you are not asked again. See the privacy policy.

50 mg and 100 mg are common label sizes, not doses. Only the vial size is preset. Water and amount start empty.

How much bacteriostatic water to add to a 100 mg vial changes only the concentration, not the amount of peptide in the vial. For the mixing steps, see how to reconstitute peptides; for the diluent, see BAC water for peptides. The full tool is at /calculators/reconstitution.

Side effects reported

Side-effect table with rates and study types.
SourceWhat was reportedRateStudy type
Mulder 1994[9], topical gelUlcer infection, lower with GHK-Cu7% vs 34% with vehicleHuman RCT
Bo 2026[6], 2% serumNo serious side effects or allergic reactions0 serious events in 18 peopleSmall human RCT
Lee 2016[20], GHK + 5-ALA (no copper stated)No adverse events0 in all 3 groupsSmall human RCT
Tanaka 2018[22], 14-ingredient scalp injectionPain, bleeding, swelling, dizziness, itching, redness4.2% minor complications; cannot be attributed to GHK-CuSmall human study
FDA safety page[12]Injectable: possible immune reactions from clumping and impuritiesConcern, no rateRegulator
openFDA[1]Injectable products recalled for sterility and process failures3 recalls; product quality, not a clinical rateRegulator

There are no human data on injection-site reactions, copper overload or long-term injected use. Side-effect counts from app users or forums are self-reports, not study data, and we do not include them.

Is GHK-Cu FDA approved? Status timeline

Dated FDA, HHS and WADA status, 2020 to 2027.

No. GHK-Cu has never been approved by FDA as a drug, so it has no FDA label and no NDC. FDA treats it as a bulk substance that has been nominated for use by compounding pharmacies[14].

  1. 2020-11-30

    Class II recall of an injectable GHK-Cu vial for lack of sterility assurance (D-0141-2021).

    openFDA enforcement records[1] Regulator
  2. 2025-07-30

    Class II recall of GHK-Cu for injection, all strengths, for lack of sterility assurance (D-0051-2026).

    openFDA enforcement records[1] Regulator
  3. 2026-04-15

    Injectable GHK-Cu leaves FDA category 2 because its nominators withdrew it. Leaving the list does not make it legal to compound.

    Frier Levitt summary of the FDA notice[30] Regulator
  4. 2026-04-22

    Non-injectable GHK-Cu is removed from category 1 after nominations are withdrawn.

    FDA 503A nominated substances list[14] Regulator
  5. 2026-05-14

    A nominator clarifies it meant to withdraw only the injectable route. "GHK-Cu (except for injectable routes of administration)" returns to category 1. FDA plans to consult its advisory committee before the end of February 2027.

    FDA 503A nominated substances list, updated 2026-05-14[14] Regulator
  6. 2026-07-23

    FDA advisory committee votes 8-6-1 to recommend BPC-157, KPV and TB-500 for the 503A list. GHK-Cu is not on the agenda; injectable GHK-Cu is to be reviewed separately.

    DLA Piper summary of the meeting[31] Regulator
  7. 2026-10-19

    Class II recall of an injectable GHK-Cu multi-dose vial for lack of processing controls (D-0129-2027).

    openFDA enforcement records[1] Regulator
  8. 2026-10-30

    HHS publishes a draft enforcement-discretion policy for compounding certain peptides. GHK-Cu is not covered.

    Federal Register 91 FR 68526[32] Regulator
  9. By end of Feb 2027

    Planned FDA advisory committee review of injectable GHK-Cu.

    FDA 503A nominated substances list[14] Regulator

Can pharmacies compound injectable GHK-Cu? Injectable GHK-Cu is on no 503A list, and leaving category 2 did not make it eligible[14]. The HHS policy published on 2026-10-30 is a draft, and law-firm summaries of its Appendix A do not include GHK-Cu[32]. Topical GHK-Cu sits in category 1, which covers non-injectable routes only.

Does GHK-Cu have an NDC? No. An NDC is issued for marketed drug products, and no GHK-Cu drug product has FDA approval.

Sport (WADA). GHK-Cu is not named on the WADA Prohibited List[33]. The S0 catch-all for substances without government approval for human therapeutic use probably applies. Athletes should check with their anti-doping body before using it.

GHK-Cu compared with minoxidil and other options

GHK-Cu vs minoxidil. Minoxidil is an FDA-approved over-the-counter hair regrowth drug[34]. GHK-Cu has no approval for hair, and its best hair evidence is the 18-person eyebrow trial[6]. No head-to-head human trial of GHK-Cu against minoxidil has been published. Claims that a study showed GHK-Cu beating minoxidil name no study we could find in PubMed or elsewhere.

Skin-care copper peptide vs injected GHK-Cu. All the human trials are topical. Injected GHK-Cu has no trial and three FDA recalls[1]. Results from creams and serums say nothing about injections.

GHK-Cu in blends and with other drugs. GHK-Cu is one of four peptides in the KLOW blend, which also contains KPV. No human study has tested GHK-Cu together with BPC-157, adalimumab (Humira) or any other drug.

GHK-Cu: questions people ask

Direct answers to what people search for. Bracketed numbers point to the sources at the end; the sections above have the detail.

What does GHK-Cu actually mean?

It is a small peptide, GHK, bound to copper (Cu). G, H and K are the letters for its three amino acids: glycine, histidine and lysine[13].

Is GHK-Cu an approved drug?

No. FDA has never approved it. Creams and other non-injected forms are on an FDA list pharmacies can work from for now. The injected form is on no list[14].

Can my pharmacy make GHK-Cu shots for me?

Not under any current FDA list. Injected GHK-Cu is on no list, and the HHS draft policy from October 2026 leaves it out. FDA plans to review it by the end of February 2027.

How much GHK-Cu should I inject?

No one knows. No study has tested GHK-Cu shots in people, so there is no studied dose[11].

What strength did the cream and serum studies use?

A 2% serum twice a day for 12 weeks[6] and a 0.4% cream[8]. These were study products, not advice.

Will GHK-Cu grow my hair back? Is it better than minoxidil?

No one knows yet. One trial of 18 people found more eyebrow hairs on the treated side[6]. No trial has compared it with minoxidil.

Will a copper peptide serum irritate my skin?

In the eyebrow trial, none of 18 people had a serious side effect or an allergic reaction. That group is too small to rule out rare reactions. For shots there are no human safety data, and FDA flags a possible immune reaction.

I compete in sport. Is GHK-Cu banned?

It is not named on the WADA list. But WADA’s S0 rule for unapproved substances probably covers it. Check with your anti-doping body.

Sources

  1. 1.openFDA recall records for GHK-Cu Regulator
  2. 2.MedWatch
  3. 3.MedlinePlus: Anaphylaxis
  4. 4.MedlinePlus: Contact dermatitis
  5. 5.2026 systematic review, 20 studies (PMID 42619529) Small human study
  6. 6.Bo 2026, eyebrow trial (Procedia Multidiscip Res) Small human study
  7. 7.Miller 2006, after laser resurfacing (PMID 16847171) Human randomised trial
  8. 8.Bishop 1992, venous ulcers (PMID 1495150) Human randomised trial
  9. 9.Mulder 1994, diabetic foot ulcers (PMID 17147644) Human randomised trial
  10. 10.PMID 39963574
  11. 11.2026 orthopaedic review, no clinical data for injection (PMID 41476424) Animal
  12. 12.FDA: bulk substances that may present significant safety risks Regulator
  13. 13.Pickart & Margolina 2018, review (PMID 29986520) Cell
  14. 14.FDA 503A nominated substances list, 2026-05-14 Regulator
  15. 15.PMID 4349963
  16. 16.PMID 26236730
  17. 17.PMID 36905132
  18. 18.PMID 25384620
  19. 19.Mateescu 2026 review, pharmacokinetics (PMID 42797253) Cell
  20. 20.Lee 2016, PMID 27489425
  21. 21.PMID 29482481
  22. 22.PMID 30057663
  23. 23.PMID 39449909
  24. 24.PMID 41001334
  25. 25.PMID 3169264
  26. 26.PMID 15655171
  27. 27.PMID 37257226
  28. 28.CuHeal topical gel trial (NCT07437586) Trial registry
  29. 29.PMID 17703734
  30. 30.Frier Levitt summary of the FDA notice
  31. 31.DLA Piper summary of the meeting
  32. 32.HHS draft peptide policy, 91 FR 68526 Regulator
  33. 33.WADA Prohibited List
  34. 34.DailyMed label
On this pageAt a glanceWhat the trials saw, week by weekLiving with it day to daySide effects: what's known and when to get helpIs it working? How to track itYour appointment checklist (dermatologist or prescriber)What is GHK-Cu?What has been studied in peopleSkin and hair: what the trials foundGHK-Cu injection: what the evidence saysGHK-Cu doses studiedGHK-Cu vial calculatorSide effects reportedIs GHK-Cu FDA approved? Status timelineGHK-Cu compared with minoxidil and other optionsGHK-Cu: questions people askSources